GSK plc
Source: SEC Form 13F · as of Mar 2026GSK plc holds 5 biotech & pharma companies tracked by BioSniper, totaling $161.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
5
Total value held
$161.9M
BioSniper AIPage evidence connected
Prepared research question
What matters most for BioNTech SE (BNTX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| BNTXBioNTech SE | 889,824 | $79.1M |
| IDYAIDEAYA Biosciences, Inc. | 1,333,333 | $44.4M |
| CYTKCYTOKINETICS INC | 340,434 | $22.4M |
| FULCFulcrum Therapeutics, Inc. | 1,785,714 | $13.7M |
| RGNXREGENXBIO Inc. | 271,456 | $2.3M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.